As a global leader in influenza vaccine manufacturing, Seqirus offers a portfolio of pandemic vaccines and services which are tailored to rapid response.
Learn more
)
PRODUCTS
OUR PRODUCTS
Seqirus markets and distributes a number of vaccines and pharmaceutical products to ensure a comprehensive range of products are available to the New Zealand market.
- Healthcare professionals who want to know more about a Seqirus product,
- and individuals who have been prescribed a Seqirus product
Influenza
| Afluria® Quad | Inactivated Quadrivalent Influenza vaccine (split viron) |
|
For the prevention of influenza in persons aged 3 years and over. MORE INFORMATION |
| Afluria® Quad Junior| Inactivated Quadrivalent Influenza vaccine (split viron) |
|
For the prevention of influenza in children aged 6 months to 35 months inclusive. MORE INFORMATION |
| Fluad®| Inactivated Influenza Vaccine, Adjuvanted |
|
For the prevention of influenza in persons aged 65 years and over. MORE INFORMATION |
In-Licensed Products
| ADT™ Booster | Diphtheria and Tetanus vaccine (adsorbed) |
|
For the prevention of diphtheria and tetanus. MORE INFORMATION |
| BCG Vaccine SSI | Live attenuated Mycobacterium bovis BCG (Bacillus Calmette-Guerin) vaccine |
|
For active immunisation against tuberculosis. MORE INFORMATION |
| Dukoral® | Oral inactivated cholera vaccine |
|
For prevention of cholera and of travellers’ diarrhoea caused by serogroup O1 Vibrio cholera and heat-labile toxin-producing enterotoxigenic Escherichia coli (ETEC). MORE INFORMATION |
| Gardasil® 9 | Human Papillomavirus 9-valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) vaccine, Recombinant |
|
In women aged 9-45 years, for the prevention of cervical, vulvar, vaginal and anal cancer, precancerous or dysplastic lesions, genital warts and infection caused by Human Papillomavirus (HPV) types 6, 11, 16, 18, 31, 45, 52 and 58. In men aged 9-26 years for the prevention of anal cancer, precancerous or dysplastic lesions, external genital lesions and infection caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58. MORE INFORMATION |
| Jespect® | Inactivated Japanese Encephalitis vaccine |
|
For the prevention of Japanese Encephalitis infection. MORE INFORMATION |
| Tramal® | Tramadol Hydrochloride |
|
Used to treat moderate to severe pain. MORE INFORMATION |
| Vimpat® | Lacosamide |
|
Used in conjunction with other medicines to control epilepsy. MORE INFORMATION |
| Vivotif® Oral | Oral, live, attenuated Typhoid vaccine |
|
For the prevention of typhoid fever. MORE INFORMATION |
DUKORAL® and JESPECT® are registered trademarks of Valneva Sweden AB.
GARDASIL® 9 is a registered trademark of Merck & Co. Inc Whitehouse Station, NJ, USA.
TRAMAL® is a registered trademark of Grunenthal GmbH used by Seqirus as authorised user.
VIMPAT® is a registered trademark used by UCB Pharma GmbH under license.
VIVOTIF® is a Registered Trademark of PaxVax Berna GmbH, Switzerland.
All other trademarks are registered by Seqirus UK Limited or its affiliates in one or more jurisdictions.
SEQ/CORP/0819/0021